CN1208322C - 二氢吲哚和四氢喹啉衍生物 - Google Patents

二氢吲哚和四氢喹啉衍生物 Download PDF

Info

Publication number
CN1208322C
CN1208322C CNB018210120A CN01821012A CN1208322C CN 1208322 C CN1208322 C CN 1208322C CN B018210120 A CNB018210120 A CN B018210120A CN 01821012 A CN01821012 A CN 01821012A CN 1208322 C CN1208322 C CN 1208322C
Authority
CN
China
Prior art keywords
methyl
dihydro
allyl
amino
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB018210120A
Other languages
English (en)
Chinese (zh)
Other versions
CN1481366A (zh
Inventor
J·埃比
J·艾克曼
A·楚乔洛夫斯基
H·德姆洛
O·莫兰德
S·瓦尔鲍姆
T·维勒尔
N·潘戴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1481366A publication Critical patent/CN1481366A/zh
Application granted granted Critical
Publication of CN1208322C publication Critical patent/CN1208322C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
CNB018210120A 2000-12-21 2001-12-12 二氢吲哚和四氢喹啉衍生物 Expired - Fee Related CN1208322C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00128063.5 2000-12-21
EP00128063 2000-12-21

Publications (2)

Publication Number Publication Date
CN1481366A CN1481366A (zh) 2004-03-10
CN1208322C true CN1208322C (zh) 2005-06-29

Family

ID=8170751

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB018210120A Expired - Fee Related CN1208322C (zh) 2000-12-21 2001-12-12 二氢吲哚和四氢喹啉衍生物

Country Status (15)

Country Link
US (2) US6706751B2 (enExample)
EP (1) EP1358162B1 (enExample)
JP (1) JP4068459B2 (enExample)
KR (1) KR100530408B1 (enExample)
CN (1) CN1208322C (enExample)
AR (1) AR035408A1 (enExample)
AT (1) ATE317386T1 (enExample)
AU (2) AU1917602A (enExample)
BR (1) BR0116263A (enExample)
CA (1) CA2431100C (enExample)
DE (1) DE60117096T2 (enExample)
ES (1) ES2257381T3 (enExample)
MX (1) MXPA03005395A (enExample)
WO (1) WO2002050041A1 (enExample)
ZA (1) ZA200304646B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040522A1 (es) 2002-05-29 2004-09-28 Novartis Ag Derivados de diarilurea dependientes de la cinasa de proteina
HRP20050181A2 (en) * 2002-08-29 2006-03-31 Merck & Co. Inc. Indoles having anti-diabetic activity
JP4479656B2 (ja) * 2003-08-08 2010-06-09 宇部興産株式会社 アルキニル基置換縮合ヘテロ環化合物及びその製法並びにそれを使用する有機エレクトロルミネッセンス素子
TWI329102B (en) * 2006-08-15 2010-08-21 Nat Health Research Institutes Thiourea compounds and method for inhibiting hepatitis c virus infection
WO2008124300A1 (en) * 2007-04-10 2008-10-16 National Health Research Institutes Hepatitis c virus inhibitors
WO2008154091A1 (en) * 2007-06-08 2008-12-18 National Health Research Institutes Thiourea derivatives
TWI361808B (en) * 2008-01-08 2012-04-11 Nat Health Research Institutes Imidazolidinone and imidazolidinethione derivatives
US8198284B2 (en) * 2008-04-30 2012-06-12 National Health Research Institutes Treatment of neurodegenerative disorders with thiourea compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997542A (en) * 1975-06-23 1976-12-14 Sterling Drug Inc. 1-(Halogenated-acetyl)-1,2,3,4-tetrahydro-6-quinolinols and esters thereof
NZ227042A (en) 1987-11-27 1991-05-28 Banyu Pharma Co Ltd Substituted alkylamine derivatives and pharmaceutical compositions
US5288749A (en) 1991-12-20 1994-02-22 Abbott Laboratories Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
TW438774B (en) 1993-07-14 2001-06-07 Hoffmann La Roche Pharmaceutical composition for lowering cholesterol containing phenalkylamines and certain novel phenalkylamines
AU1608397A (en) 1996-02-02 1997-08-22 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
DE19727117A1 (de) 1997-06-26 1999-01-07 Boehringer Ingelheim Pharma Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US7229986B2 (en) 2000-05-16 2007-06-12 Takeda Pharmaceutical Company Ltd. Melanin-concentrating hormone antagonist

Also Published As

Publication number Publication date
JP2004519441A (ja) 2004-07-02
US7102007B2 (en) 2006-09-05
AR035408A1 (es) 2004-05-26
CN1481366A (zh) 2004-03-10
ATE317386T1 (de) 2006-02-15
CA2431100C (en) 2009-03-24
BR0116263A (pt) 2003-12-30
US20030004156A1 (en) 2003-01-02
DE60117096D1 (de) 2006-04-20
EP1358162A1 (en) 2003-11-05
KR100530408B1 (ko) 2005-11-22
WO2002050041A1 (en) 2002-06-27
AU2002219176B2 (en) 2006-02-09
JP4068459B2 (ja) 2008-03-26
US20050020624A1 (en) 2005-01-27
KR20030063453A (ko) 2003-07-28
ZA200304646B (en) 2004-09-13
EP1358162B1 (en) 2006-02-08
AU1917602A (en) 2002-07-01
MXPA03005395A (es) 2003-09-25
CA2431100A1 (en) 2002-06-27
US6706751B2 (en) 2004-03-16
DE60117096T2 (de) 2006-11-23
ES2257381T3 (es) 2006-08-01

Similar Documents

Publication Publication Date Title
CN1193025C (zh) 新的1,3－二氢－2h－吲哚－2－酮衍生物,它们的制备方法以及含有它们的药物组合物
CN1192773C (zh) 环胺ccr3拮抗剂
CN1040986A (zh) 环烷基取代的戊二酰胺衍生物的制备
CN1087904A (zh) 羧酸衍生物，含有这些化合物的药物组合物以及其制备方法
CN1050376A (zh) 酰基辅酶a：胆甾醇酰基转移酶抑制剂
CN1500081A (zh) 乙内酰硫脲及其在治疗糖尿病方面的用途
CN1468211A (zh) 亚硝基二苯胺衍生物
CN1030701C (zh) 吲哚衍生物的制备方法
CN1068815A (zh) 用做抗炎及抗变性剂的新的取代氮杂环丁酮
CN1047859A (zh) 苯并环烷烃衍生物及其制备方法
CN1011780B (zh) 苯氧基乙酸衍生物的制备方法
CN1720227A (zh) N－芳基磺酰基－3－氨基烷氧基吲哚
CN1208322C (zh) 二氢吲哚和四氢喹啉衍生物
CN1882532A (zh) 氨基烷基酰胺取代的环己基衍生物
CN101044113A (zh) 取代了的吲哚化合物、其制备和在药物中的应用
CN1281585C (zh) 具有稠环基团的环二胺化合物
CN1053063A (zh) 喹唑啉衍生物及其制备方法
CN1065243C (zh) 新的二氮杂萘衍生物
CN1100425A (zh) 噻唑并嘧啶衍生物
CN1468214A (zh) 新型氨基环己烷衍生物
CN1296357C (zh) 杂芳基取代的氨基环己烷衍生物
CN1208329C (zh) 新的苯胺衍生物
CN1261429C (zh) 降胆固醇的苯并「b」噻吩和苯并「d」异噻唑
CN1231466C (zh) 新型哌啶衍生物
CN1906154A (zh) 氨基醇衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050629

Termination date: 20101212